Nanotechnology Now

Our NanoNews Digest Sponsors

Heifer International

Wikipedia Affiliate Button

Home > Press > First Grant Awarded By Kay Yow/WBCA Cancer Fund to be Announced at the Women’s NCAA Final Four in St. Louis

Abstract:
Grant will be used for early detection research in breast cancer patients

First Grant Awarded By Kay Yow/WBCA Cancer Fund to be Announced at the Women’s NCAA Final Four in St. Louis

St. Louis, MO | Posted on April 4th, 2009

The Kay Yow/Women's Basketball Coaches Association Cancer Fund and The V Foundation announce that Michael Welch, Ph.D. and John-Stephen Tyler, Ph.D. will be recipients of the first research grant awarded with money raised by the Kay Yow/WBCA Fund. Awarded during the NCAA Women's Final Four weekend in St. Louis, Missouri, the grant will be given to fund a breast cancer research project at the Siteman Cancer Center at Washington University School of Medicine and Barnes-Jewish Hospital, also located in St. Louis.

The Kay Yow/WBCA Cancer Fund was created in 2007 by Kay Yow, the longtime North Carolina State women's basketball coach, in collaboration with the WBCA and The V Foundation for Cancer Research. "The Kay Yow/WBCA Cancer Fund, in partnership with The V Foundation, is thrilled to be allocating our first grant of $100,000 to Dr. Michael Welch from Washington University in St. Louis, Missouri. The women's basketball community is committed to finding an answer in the fight against women's cancers through raising money for scientific research as a collective whole. Thank you to everyone who has supported this truly wonderful cause," says Marsha Sharp, President of the Kay Yow/WBCA Cancer Fund.

The Kay Yow/WBCA Cancer Fund is dedicated to the fight against women's cancers through raising money for scientific research, assisting the underserved and unifying people for a common cause. "We are thrilled to have accomplished this tremendous feat in Kay's honor," said CEO of The V Foundation Nick Valvano. "It is a true tribute to Kay that so many people have embraced her cause and supported the Fund which she established."

This grant in particular will be used for a project titled "Targeted Nanoparticles Optimized for Breast Cancer Diagnosis and Therapy," in which the principal investigators will study methods to improve the diagnosis and treatment of breast cancer through nanotechnology.This research will be conducted in hopes that doctors will be able to find cancerous cells even before a mammogram can detect them.

"Thanks to the wonderful support of the Kay Yow/WBCA Cancer Fund and the V Foundation - we will be able to realize our goal of studying ways to earlier diagnose breast cancer using nanotechnology," says Timothy Eberlein, M.D., director of Siteman Cancer Center and the Bixby Professor and chairman of the Department of Surgery at the School of Medicine. "Our research also has opened the possibility of using this exciting new technology for targeted therapy, which promises to be more effective and less toxic. We are grateful to the Kay Yow/WBCH Cancer Fund and the V Foundation for having the confidence in our research to award this valuable support."

####

About Kay Yow/WBCH Cancer Fund
The Kay Yow/WBCA Cancer Fund is a 501 c(3) charitable organization committed to being a part of finding an answer in the fight against women’s cancers through raising money for scientific research, assisting the underserved and unifying people for a common cause.

About The V Foundation for Cancer Research

The V Foundation for Cancer Research was founded in 1993 by ESPN and the late Jim Valvano, the legendary North Carolina State basketball coach and ESPN commentator. Since 1993, The Foundation has raised more than $80 million to fund cancer research grants nationwide. It awards 100 percent of direct cash donations and net proceeds of events directly to cancer research and related programs. The Foundation, which has received six consecutive top 4-star ratings from Charity Navigator, awards grants through a competitive awards process strictly supervised by a Scientific Advisory Board. For more information about The V Foundation, or to make a donation, please visit www.jimmyv.org.

About the WBCA

Founded in 1981, the WBCA promotes women’s basketball by unifying coaches at all levels to develop a reputable identity for the sport and to foster and promote the development of the game as a sport for women and girls. For additional information about the WBCA, please visit wbca.org.

About Siteman Cancer Center

Siteman Cancer Center is the only federally designated Comprehensive Cancer Center within a 240-mile radius of St. Louis. Siteman Cancer Center is composed of the combined cancer research and treatment programs of Barnes-Jewish Hospital and Washington University School of Medicine. Siteman has satellite locations in West County and St. Peters, in addition to its full-service facility at Washington University Medical Center on South Kingshighway.

Contacts:
Sherrie Mazur
Director of Marketing and Communication
The V Foundation
919/380-9509

Copyright © NCAA

If you have a comment, please Contact us.

Issuers of news releases, not 7th Wave, Inc. or Nanotechnology Now, are solely responsible for the accuracy of the content.

Bookmark:
Delicious Digg Newsvine Google Yahoo Reddit Magnoliacom Furl Facebook

Related Links

Siteman Cancer Center

Barnes-Jewish Hospital

Related News Press

News and information

Graphene shows unique potential to exceed bandwidth demands of future telecommunications October 12th, 2018

High-performance self-assembled catalyst for SOFC October 12th, 2018

180 Degree Capital Corp. Announces New Portfolio Holdings – Airgain, Inc., EMCORE Corporation, Lantronix, Inc. and PDL BioPharma, Inc. October 12th, 2018

TUBALL single wall carbon nanotubes: No ecotoxicity found, unlike other carbon nanotubes October 12th, 2018

Investments/IPO's/Splits

180 Degree Capital Corp. Announces New Portfolio Holdings – Airgain, Inc., EMCORE Corporation, Lantronix, Inc. and PDL BioPharma, Inc. October 12th, 2018

Arrowhead Pharmaceuticals Reports Inducement Grants under NASDAQ Marketplace Rule 5635(c)(4) September 25th, 2018

Nanometrics Announces Participation in Upcoming Investor Conferences July 25th, 2018

Nanometrics to Participate in the 10th Annual CEO Investor Summit 2018: Accredited investor and publishing research analyst event held concurrently with SEMICON West and Intersolar 2018 in San Francisco June 28th, 2018

Nanomedicine

180 Degree Capital Corp. Announces New Portfolio Holdings – Airgain, Inc., EMCORE Corporation, Lantronix, Inc. and PDL BioPharma, Inc. October 12th, 2018

Tracking a Killer: UCSB, UCSD and SBP researchers trace the complex and variable pathways to the deadly condition known as sepsis October 12th, 2018

Arrowhead to Present Late-Breaking Clinical Data on ARO-AAT and ARO-HBV at AASLD Liver Meeting® 2018 October 11th, 2018

Nano Pharmaceutical Developed to Target Cancer Cells October 10th, 2018

Announcements

Researchers quickly harvest 2-D materials, bringing them closer to commercialization: Efficient method for making single-atom-thick, wafer-scale materials opens up opportunities in flexible electronics October 12th, 2018

High-performance self-assembled catalyst for SOFC October 12th, 2018

180 Degree Capital Corp. Announces New Portfolio Holdings – Airgain, Inc., EMCORE Corporation, Lantronix, Inc. and PDL BioPharma, Inc. October 12th, 2018

TUBALL single wall carbon nanotubes: No ecotoxicity found, unlike other carbon nanotubes October 12th, 2018

Grants/Sponsored Research/Awards/Scholarships/Gifts/Contests/Honors/Records

Tracking a Killer: UCSB, UCSD and SBP researchers trace the complex and variable pathways to the deadly condition known as sepsis October 12th, 2018

Columbia Engineers Build Smallest Integrated Kerr Frequency Comb Generator October 9th, 2018

Light makes Rice U. catalyst more effective: Halas lab details plasmonic effect that allows catalyst to work at lower energy October 5th, 2018

Scientists use nanoparticles to improve chemotherapy response, boost anti-tumor immunity: U of T scientists use nanoparticles to improve chemotherapy response and boost anti-tumor immunity in breast cancer October 2nd, 2018

Nanobiotechnology

180 Degree Capital Corp. Announces New Portfolio Holdings – Airgain, Inc., EMCORE Corporation, Lantronix, Inc. and PDL BioPharma, Inc. October 12th, 2018

Tracking a Killer: UCSB, UCSD and SBP researchers trace the complex and variable pathways to the deadly condition known as sepsis October 12th, 2018

Arrowhead to Present Late-Breaking Clinical Data on ARO-AAT and ARO-HBV at AASLD Liver Meeting® 2018 October 11th, 2018

Nano Pharmaceutical Developed to Target Cancer Cells October 10th, 2018

NanoNews-Digest
The latest news from around the world, FREE



  Premium Products
NanoNews-Custom
Only the news you want to read!
 Learn More
NanoStrategies
Full-service, expert consulting
 Learn More











ASP
Nanotechnology Now Featured Books




NNN

The Hunger Project